Anti-MUC1/ ADMCKD/ ADMCKD1 monoclonal antibody

Anti-MUC1/ ADMCKD/ ADMCKD1 antibody for FACS & in-vivo assay

Target products collectionGo to MUC1/MUC1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T18779-Ab-1/ GM-Tg-hg-T18779-Ab-2Anti-Human MUC1 monoclonal antibodyHuman
GM-Tg-rg-T18779-Ab-1/ GM-Tg-rg-T18779-Ab-2Anti-Rat MUC1 monoclonal antibodyRat
GM-Tg-mg-T18779-Ab-1/ GM-Tg-mg-T18779-Ab-2Anti-Mouse MUC1 monoclonal antibodyMouse
GM-Tg-cynog-T18779-Ab-1/ GM-Tg-cynog-T18779-Ab-2Anti-Cynomolgus/ Rhesus macaque MUC1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T18779-Ab-1/ GM-Tg-felg-T18779-Ab-2Anti-Feline MUC1 monoclonal antibodyFeline
GM-Tg-cang-T18779-Ab-1/ GM-Tg-cang-T18779-Ab-2Anti-Canine MUC1 monoclonal antibodyCanine
GM-Tg-bovg-T18779-Ab-1/ GM-Tg-bovg-T18779-Ab-2Anti-Bovine MUC1 monoclonal antibodyBovine
GM-Tg-equg-T18779-Ab-1/ GM-Tg-equg-T18779-Ab-2Anti-Equine MUC1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T18779-Ab-1/ GM-Tg-hg-T18779-Ab-2; GM-Tg-rg-T18779-Ab-1/ GM-Tg-rg-T18779-Ab-2;
GM-Tg-mg-T18779-Ab-1/ GM-Tg-mg-T18779-Ab-2; GM-Tg-cynog-T18779-Ab-1/ GM-Tg-cynog-T18779-Ab-2;
GM-Tg-felg-T18779-Ab-1/ GM-Tg-felg-T18779-Ab-2; GM-Tg-cang-T18779-Ab-1/ GM-Tg-cang-T18779-Ab-2;
GM-Tg-bovg-T18779-Ab-1/ GM-Tg-bovg-T18779-Ab-2; GM-Tg-equg-T18779-Ab-1/ GM-Tg-equg-T18779-Ab-2
Products NameAnti-MUC1 monoclonal antibody
Formatmab
Target NameMUC1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-MUC1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-INN-770Pre-Made Cantuzumab Ravtansine Biosimilar, Whole Mab Adc, Anti-Muc1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therapeutic antibody Drug Conjugate
    BiosimilarGMP-Bios-INN-1052Pre-Made Yttrium (90Y) Clivatuzumab Tetraxetan Biosimilar, Radiolabelled Antibody, Anti-Muc1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therapeutic antibody
    BiosimilarGMP-Bios-INN-769Pre-Made Cantuzumab Mertansine Biosimilar, Whole Mab Adc, Anti-Muc1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therapeutic antibody Drug Conjugate
    BiosimilarGMP-Bios-INN-997Pre-Made Sontuzumab Biosimilar, Whole Mab, Anti-Muc1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therapeutic antibody
    BiosimilarGMP-Bios-ab-236Pre-Made Gatipotuzumab biosimilar, Whole mAb, Anti-MUC1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therapeutic antibody
    BiosimilarGMP-Bios-ab-112Pre-Made Clivatuzumab biosimilar, Whole mAb Radiolabelled, Anti-MUC1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therapeutic antibody
    BiosimilarGMP-Bios-ab-092Pre-Made Cantuzumab biosimilar, Whole mAb ADC, Anti-MUC1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therapeutic antibody
    BiosimilarGMP-Bios-INN-922Pre-Made Nacolomab Tafenatox biosimilar, Fusion Protein, Nacolomab-Anti-MUC1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therapeutic antibody fused with Staphylococcus aureus enterotoxin A
    BiosimilarGMP-Bios-INN-784Pre-Made Clivatuzumab Tetraxetan Biosimilar, Whole Mab Adc, Anti-Muc1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therapeutic antibody Drug Conjugate
    BiosimilarGMP-Bios-ab-426Pre-Made PankoMab biosimilar, Whole mAb, Anti-MUC1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therapeutic antibody
    BiosimilarGMP-Bios-INN-839Pre-Made Epitumomab Cituxetan Biosimilar, Radiolabelled Antibody, Anti-Muc1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therapeutic antibody
    Target AntigenProducts DevelopingMulti-species MUC1/ ADMCKD/ ADMCKD1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMAP000530Human MUC1 Adenovirus particle
    ORF Viral VectorpGMAD000430human MUC1 Adenovirus plasmid
    ORF Viral VectorpGMAD000096human MUC1 Adenovirus plasmid
    ORF Viral VectorvGMAD000430human MUC1 Adenovirus particle
    ORF Viral VectorpGMAP000530Human MUC1 Adenovirus plasmid
    ORF Viral VectorvGMLP000558human MUC1 Lentivirus particle
    ORF Viral VectorvGMAD000096human MUC1 Adenovirus particle
    ORF Viral VectorpGMLP000558human MUC1 Lentivirus plasmid


    Target information

    Target IDGM-T18779
    Target NameMUC1
    Gene ID4582,17829,24571,717546,448784,101093832,281333,100063415
    Gene Symbol and SynonymsADMCKD,ADMCKD1,ADTKD2,CA 15-3,Ca15-3,CD227,EMA,H23AG,KL-6,MAM6,MCD,MCKD,MCKD1,MUC-1,MUC-1/SEC,MUC-1/X,MUC1,MUC1/ZD,mucin,PEM,PEMT,PUM
    Uniprot AccessionP15941,Q8WML4
    Uniprot Entry NameMUC1_HUMAN,MUC1_BOVIN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, Immuno-oncology Target, INN Index
    DiseaseOvary Cancer
    Gene EnsemblENSG00000185499
    Target ClassificationCheckpoint-Immuno Oncology

    The target: MUC1, gene name: MUC1, also named as ADMCKD, ADMCKD1, CA 15-3, CD227, EMA, H23AG, KL-6, MAM6, MCD, MCKD, MCKD1, MUC-1, MUC-1/SEC, MUC-1/X/ZD, PEM, PEMT, PUM, MUC1. This gene encodes a membrane-bound protein that is a member of the mucin family. Mucins are O-glycosylated proteins that play an essential role in forming protective mucous barriers on epithelial surfaces. These proteins also play a role in intracellular signaling. This protein is expressed on the apical surface of epithelial cells that line the mucosal surfaces of many different tissues including lung, breast stomach and pancreas. This protein is proteolytically cleaved into alpha and beta subunits that form a heterodimeric complex. The N-terminal alpha subunit functions in cell-adhesion and the C-terminal beta subunit is involved in cell signaling. Overexpression, aberrant intracellular localization, and changes in glycosylation of this protein have been associated with carcinomas. This gene is known to contain a highly polymorphic variable number tandem repeats (VNTR) domain. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Feb 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.